• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Hands-Free Texting for Paralysis Patients: Synchron Integrates Generative AI into BCI

by Fred Pennic 07/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Synchron, a leading innovator in brain-computer interface (BCI) technology, has announced a groundbreaking integration of generative AI into its BCI platform. 

– The integration, powered by OpenAI, empowers individuals with severe paralysis to interact with the digital world through thought-controlled texting, offering a new level of communication and independence.

Unlocking Communication with Thought

The novel BCI chat feature leverages OpenAI’s advanced generative AI system to offer intuitive and user-friendly communication. Key features include:

  • Automated Texting Prompts: The system suggests contextual prompts for texting and chatting, categorized by the user’s emotions. This intelligent assistance simplifies communication and reduces the cognitive burden for users.
  • Natural Conversational Flow: OpenAI’s multimodal GPT technology allows for natural and real-time interactions. This is crucial for individuals with neurological disorders who may struggle to generate complex responses that adapt to their environment.
  • Efficiency and Speed: The BCI platform facilitates faster response times and texting at natural conversational speeds, enhancing the overall user experience.

Patient-Centric Innovation

Synchron prioritizes patient needs in its development efforts. This integration of generative AI reflects their commitment to pushing the boundaries of neurotechnology and improving the lives of those with paralysis. It’s important to note that Synchron prioritizes user privacy and does not share BCI user’s brain data with OpenAI.

Beyond Texting: Expanding BCI Capabilities

This advancement paves the way for further integration of AI into the BCI platform. Synchron will continuously evaluate state-of-the-art large language models (LLMs) to best serve the evolving needs of BCI users.

Synchron’s Mission: Empowering Millions

Synchron’s BCI technology utilizes a minimally-invasive endovascular procedure to implant the device near the brain’s motor cortex. This allows for the detection and transmission of motor signals, enabling users to control devices with hands-free point-and-click functionality. The integration of generative AI further enhances this technology, empowering millions of people with upper limb impairment to connect with the world on a deeper level.

“Our users have lost the ability to make choices due to neurological disorders. Generative AI can offer predictions that are contextual to your environment, and the BCI enables individual choices to be made,” said Tom Oxley, CEO & Founder, Synchron. “BCIs preserve and extend a fundamental human right: the freedom of expression. We take our autonomy for granted, until it is gone. This is a pivotal moment at the convergence of powerful technologies that can restore lives.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |